Skip to content
Editorial Open access

Does gadolinium truly enhance the active surveillance of men with prostate cancer?

Oct 2026 · BJUI Compass · Vol 7 · 0 citations · 6 references
Medicine

Abstract

This study supports bpMRI for men stably on AS who already have an mpMRI, in programmes that biopsy every PI-RADS ≥ 3 lesion: not the diagnostic scan and not a programme that watches PI-RADS 3 lesions rather than sampling them. Settling the remainder needs a prospective surveillance cohort with paired same-visit reads and lesion-level scoring on a protocol that does not switch modality mid-way. Within those limits, gadolinium enhances the image, not the surveillance.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.